does tirzepatide affect liver Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A How do GLP-1 weight loss

One potential area of concern for some patients is its effect on the digestive system, specifically in relation to a condition called gastritis

Common side effects may include nausea, vomiting, diarrhea, constipation, reflux, decreased appetite, or abdominal discomfort

For institutional researchers and independent laboratory professionals operating in the GCC, identifying a reliable supply chain requires navigating a specific set of regional challenges

But for people who need a bigger HbA1c reduction, carry excess weight, or already have heart or kidney disease, guidelines increasingly favour GLP-1 receptor agonists [1] This explains the why before we get into the how

These effects may hide warning signs such as shakiness, confusion, or fast heartbeat